//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts









Loading...
Final day for #APELSO2026 Challenging spirit, the 8th annual conference of APELSO - Asia-Pacific Extracorporeal Life Support Organization, the Asia-Pacific chapter of the ELSO - ELSO - Extracorporeal Life Support Organization in šŸ“Œ Tokyo, Japan šŸ‡ÆšŸ‡µ Congratulations for this successful event!
ā° The abstract submission deadline for #ELSO2026 is approaching - 2ļøāƒ£ DAYS ā° NO extensions All accepted abstracts will be published as a supplement in @asaiojournal.bsky.social Journal. Select abstracts may be presented live šŸŽ¤. šŸ“† September 28 - October 1, 2026 šŸ“Œ Nashville, TN šŸ–‡ļø bit.ly/ELSO2026
The effects of mechanical ventilation during VA #ECMO, systematic review aimed to summarize & describe studies investigating its effects on hemodynamics, cardiac recovery, outcomes. šŸ“– available evidence sparse/low quality, highly heterogeneous, and at considerable risk of bias. šŸ”“ rdcu.be/fnfsg
6d
13d
8d
9d
Second day of #APELSO2026, the 8th annual conference of APELSO - Asia-Pacific Extracorporeal Life Support Organization, the Asia-Pacific chapter of the @theelso.bsky.social - Extracorporeal Life Support Organization, ongoing in beautiful šŸ“Œ Tokyo, Japan šŸ‡ÆšŸ‡µ Here some pics šŸ“ø
šŸ“˜ Donation after Circulatory Death #DCD liver Tx and machine perfusion šŸ“– bit.ly/DCDLiverTx Pleased to be author of NRP circuit & perfusion chapter āš™ļø circuit 🩸 pump, driving unit, blood flow šŸ’Ø ML and gas management 🩸 reservoir 🩸 anticoagulation 🚧 NRP complications/troubleshooting šŸ“– bit.ly/DCDLiverNRP
14d
Venopulmonary #ECLS šŸ«€šŸ« ?? Hospital outcomes, complications, survival differed according to the diagnosis leading to VP #ECMO use. Younger age, male sex, lower BMI, and no CRRT use prior to cannulation confer a lower risk of death. šŸ–‡ļø bit.ly/4uRqTrr
17h
Check our latest article on #ECMO support in adult critically ill patients, including modalities & mechanisms of benefit in 🫁 respiratory, šŸ«€ cardiac & šŸ«€šŸ« cardiorespiratory failure, just out on the @atsblueeditor.bsky.social Blue Journal!! šŸ–‡ļø bit.ly/3Sk7D8m
2d
Standards for cDCDs in adults: @esottransplant.bsky.social consensus šŸ› ļø system requirements šŸ“‹ preserving & šŸ” identifying opportunities 🩺 assessment of suitability šŸ«“šŸ» communication about OD šŸ•Æļømanaging WLSM/end-of-life care āš–ļø ante-mortem interventions #FOAMcc on @transpl-int.bsky.social šŸ”“ bit.ly/4vvLkL9
Characterization of multiple organ dysfunction patterns & their associations with in-hospital mortality for children on #ECMO #PedsICU @asaiojournal.bsky.social šŸ–‡ļø bit.ly/4gmBSW3
15d
5d
#ECMO before pediatric heart #transplantation: comparing two eras šŸ«€ although #ECLS before #Tx decreased over years, survival & outcomes improved. Compared to previous decade, ECMO is associated with lower mortality and better long-term survival. #PedsICU @asaiojournal.bsky.social šŸ”— bit.ly/4fwcVHp
15d
M Velia Antonini
M Velia Antonini
M Velia Antonini
M Velia Antonini
M Velia Antonini
M Velia Antonini
#ECMO before pediatric heart #transplantation: šŸ” >1K #ECLS supported children with end-stage heart failure from UNOS Database included: 58% in era 1 (2005–14), 42% in era 2 (2015-24) šŸ«€ 52% transplanted 🪦 total waitlist mortality 34.9%; in era 2 significantly higher waitlist survival šŸ”— bit.ly/4fwcVHp
#ECLS in adult critically ill patients, modalities & mechanisms of benefit in different pathophysiological states: 🫁 respiratory ECLS šŸ«€ cardiac #ECMO & #ECPR šŸ«€šŸ« cardiorespiratory ECLS 🩺 bridging mechanisms and clinical heterogeneity in ECLS 🚧 limitations of ECLS šŸ–‡ļø bit.ly/3Sk7D8m
Venopulmonary #ECLS, an ELSO Registry analysis: šŸ” 838 patients included, July 2020 to July 2024 šŸ«€šŸ« major indications: heart failure/CS 54.4%; acute respiratory failure/#ARDS 26.6% 🚧 common adverse events included need for #CRRT or AKI, infections, arrhythmias, bleedings šŸ–‡ļø bit.ly/4uRqTrr
2d
15d
17h
Characterization of multiple organ dysfunction for children on ECMO āš–ļø starting the day of cannulation, more ODs developed in non-survivors; difference persisted throughout run/after decannulation šŸ” opportunities to investigate + intervene on risk factors in peri-cannulation period? šŸ–‡ļø bit.ly/4gmBSW3
5d